TrialCritical care (London, England)2026

Intrapulmonary penetration of ceftolozane/tazobactam and ceftazidime/avibactam administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial.

Adela Benítez-Cano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.